Biodelivery Sci Intl (BDSI) |
|
4.07 -0.13 (-3.1%)
|
01-27 02:33 |
|
Open: |
4.2 |
Pre. Close: |
4.2 |
|
High:
|
4.205 |
Low:
|
4.07 |
|
Volume:
|
908,152 |
Market Cap:
|
412M |
|
|
|
|
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.205 - 4.226 |
4.226 - 4.246 |
|
Low:
|
4.01 - 4.036 |
4.036 - 4.061 |
|
Close:
|
4.023 - 4.063 |
4.063 - 4.103 |
|
Technical analysis |
as of: 2021-01-26 4:41:29 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.41 One year: 5.83 |
| Support: |
Support1: 4.06 Support2: 3.38 |
| Resistance: |
Resistance1: 4.63 Resistance2: 4.99 |
| Pivot: |
4.38  |
| Moving Average: |
MA(5): 4.19 MA(20): 4.33
MA(100): 3.95  MA(250): 4.27 |
| MACD: |
MACD(12,26): -0.01 Signal(9): 0.04 |
| Stochastic oscillator: |
%K(14,3): 6.91 %D(3): 11.50 |
| RSI: |
RSI(14): 42.04 |
| 52-week: |
High: 5.61 Low: 2.85 Change(%): -26.0 |
| Average Vol(K): |
3-Month: 102974 10-Days: 163904 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.BDSI has closed above bottom band by 9.8%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 15 Jan 2021
BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting - GlobeNewswire
Wed, 11 Nov 2020
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18 - GlobeNewswire
Sat, 07 Nov 2020
BioDelivery Sciences International, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Yahoo Finance
Fri, 06 Nov 2020
Is BioDelivery Sciences International (NASDAQ:BDSI) Using Too Much Debt? - Yahoo Finance
Thu, 05 Nov 2020
BioDelivery Sciences Reports Strong Q3 2020 Results Nasdaq:BDSI - GlobeNewswire
Wed, 04 Nov 2020
BioDelivery Sciences Announces $25 Million Share Repurchase Program - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
101 |
| Shares Float (M) |
82 |
|
% Held by Insiders
|
2.45 |
|
% Held by Institutions
|
73.76 |
|
Shares Short (K)
|
2,470 |
|
Shares Short P. Month (K)
|
3,080 |
Stock Financials |
|
EPS
|
0.153 |
|
EPS Est This Year
|
0.120 |
|
EPS Est Next Year
|
-0.640 |
|
Book Value (p.s.)
|
0.950 |
|
Profit Margin
|
10.15 |
|
Operating Margin
|
19.19 |
|
Return on Assets (ttm)
|
8.7 |
|
Return on Equity (ttm)
|
18.1 |
|
Qtrly Rev. Growth
|
30.1 |
|
Gross Profit (p.s.)
|
0.903 |
|
Sales Per Share
|
1.443 |
|
EBITDA (p.s.)
|
0.353 |
|
Qtrly Earnings Growth
|
2550.60 |
|
Operating Cash Flow (M)
|
31 |
|
Levered Free Cash Flow (M)
|
10 |
Stock Valuations |
|
PE Ratio
|
26.60 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.28 |
|
Price to Sales
|
2.82 |
|
Price to Cash Flow
|
13.32 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
